Delivery Order SPE2DB22D3011-SPE2DB25FQ1VF
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,563.97 for IPOL Vial 5ML pharmaceutical products on October 29, 2025, with completion expected by October 30, 2025. This competitively awarded, non-set-aside contract is funded by the Defense Logistics Agency's Medical Supply Chain division and performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award utilizes firm fixed-price contract terms and represents a child delivery order under a...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a Delivery Order with a Firm Fixed Price of $1,744.16. The contract is for the supply of IPOL VIAL 5ML to the Defense Logistics Agency, a defense agency, with an ultimate completion date of May 29, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $1,150.61 to AmerisourceBergen Drug Corp for the supply of Ipol vial 5ML pharmaceutical product. This competitively awarded, firm fixed-price delivery order was issued on December 4, 2025, with an ultimate completion date of December 5, 2025. The award carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,037.64 for IPOL Vial 5ML on December 23, 2025, with an ultimate completion date of December 24, 2025. This firm fixed price, non-competitive delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be performed at the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $1,230.88 firm fixed-price delivery order by the Defense Logistics Agency on December 8, 2025, for IPOL vial 5ML (inactivated polio vaccine). This competitive award, which carries no set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,090.10 to AmerisourceBergen Drug Corp for a 5mL vial of Ipol (polio vaccine) on July 22, 2025, with an ultimate completion date of July 23, 2025. This delivery order was competitively awarded with firm fixed pricing and no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. This delivery order is a child contract issued...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, is a delivery order worth $21,347.00 for the supply of 4564938215 IPOL VIAL 5ML. The award was made by the Defense Logistics Agency, a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $45,278.31 on July 28, 2025, by the Defense Logistics Agency's Medical Supply Chain with a completion date of July 29, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $4,028.55 from the Defense Logistics Agency's Medical Supply Chain on October 27, 2025. This firm fixed price delivery order, which serves as a child contract under a larger indefinite delivery vehicle, is non-competitive and carries a completion deadline of October 28, 2025. The award reflects AmerisourceBergen's ongoing role as a critical federal...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $40,628.97 on July 21, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, with an ultimate completion date of July 22, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made through open competition with no set-aside designation, and the place of performance is located in...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB25FQ1VFDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $80,074.43 by the Defense Logistics Agency on July 17, 2025, for the supply of Ipol vial 5ml pharmaceutical products. The contract utilizes firm fixed pricing and is classified as a non-set-aside competitive award, with an ultimate completion date of July 18, 2025. Performance will be executed from the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products, vaccines, and medical supplies to support military healthcare programs worldwide. The Defense Logistics Agency's Medical Supply Chain relies on AmerisourceBergen as a critical vendor for federal medical procurement, and the company's contract portfolio demonstrates extensive experience fulfilling diverse pharmaceutical and medical supply requirements for the Department of Defense and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $80.1k | 7/17/25 |